MONTREAL and WILMINGTON, Del., Sept. 7 /PRNewswire-FirstCall/ -- Millenia Hope Inc. (OTC Bulletin Board: MLHP, FRANKFURT MLF) announced today that its subsidiary, Millenia Hope Pharmaceuticals (tradename: Millenia Hope Biopharma) has filed its SB-2 Registration Statement with the SEC, pursuant to becoming a public reporting company.
